Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
University of Pittsburgh
University of Pittsburgh
University of Pittsburgh
National Cancer Institute, Egypt
M.D. Anderson Cancer Center
Hummingbird Bioscience
University of Chicago
Maia Biotechnology
National Cancer Institute (NCI)
Istituto Oncologico Veneto IRCCS
Icahn School of Medicine at Mount Sinai
Royal Marsden NHS Foundation Trust
AVEO Pharmaceuticals, Inc.
Washington University School of Medicine
KaliVir Immunotherapeutics
Medical University of South Carolina
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Hôpital NOVO
Merck Sharp & Dohme LLC
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
M.D. Anderson Cancer Center